Promoting Support for Anti-Amyloid Alzheimer’s Therapies
![Amyloid Plaques (Ab) and Neurofibrillary Tangles (tau)](https://www.brighamhealthonamission.org/wp-content/uploads/2021/09/OAM-Selkoe-blog-1-300x208.jpg)
For over three decades, Dennis Selkoe, MD, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, has studied protein abnormalities that occur in Alzheimer’s disease (AD). In the mid-1980s, he and his colleagues at the Brigham were among the first scientists to discover that neurofibrillary tangles associated with AD were made of the tau protein. In the early 1990s, he was instrumental in developing the amyloid hypothesis, which links excess amyloid β (Aβ) in the brain to the initiation of AD, and his lab made several discoveries supporting the concept.